Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre.
Authors: Saxena, Mohith; Madabhavi, Irappa; Patel, Apurva; Panchal, Harsha; Anand, Asha
Publication: International Journal of Hematology-Oncology & Stem Cell Research, 2018, Vol 12, Issue 3, p196
ISSN: 2008-3009
Publication type: Academic Journal